Dr Shezad Malik Law Firm has offices based in Fort Worth and Dallas and represents people who have suffered catastrophic and serious personal injuries including wrongful death, caused by the negligence or recklessness of others. We specialize in Personal Injury trial litigation and focus our energy and efforts on those we represent.

Articles Posted in Product Liability

As Biomet M2a Magnum metal on metal hip replacement attorney, I have written extensively about the inherent early failure problems associated with metal on metal hips like the DePuy ASR, Pinnacle hip replacement models and others made by Biomet, Zimmer, Smith and Nephew and Wright.

Biomet-M2a-hip-failure-attorney.jpg

In recent years, concerns have emerged about the safety of all metal-on-metal hip replacement systems. The metal-on-metal design causes cobalt and chromium metallic microscopic shards to shear off from the metallic articular surfaces through the grinding wear and tear mechanism. The articular surfaces involve the metallic surfaces of the acetabular cup, femoral head and taper sleeve.

There is mounting evidence of the significant risks that the patients are exposed to; including premature device failure, osteolysis (bone loss), bone and tissue damage, metallosis (metal poisoning) and heavy metal toxicity.

As an Actos Bladder Cancer attorney I have written extensively of the alleged injuries of bladder cancer with the use of the newer diabetic drug, Actos. A Virginia man has filed lawsuit alleging that he took Actos and developed bladder cancer. The suit was filed in the U.S. District Court for the Western District of Louisiana on June 14th (Case No. 6:12-cv-1704). The case is one of many pending in the Actos multidistrict litigation (MDL No. 6:11-md-2299).

Actos_Bladder_Cancer_Attorney.jpg

What is Actos?

Actos is a type 2 diabetes medication that has been on the US market since 1999. It is manufactured by Takeda Pharmaceuticals. Actos is one of Takeda’s top-selling drugs with global sales of $4.8 billion last year; in 2008, Actos was the 10th best -selling medication in the United States.

As a DePuy ASR Recall and DePuy Pinnacle Replacement attorney, I have written extensively about the inherent problems associated with metal on metal hips like the DePuy ASR, Pinnacle hip relacement models and others made by Biomet, Zimmer, Smith and Nephew and Wright.

DePuy-ASR-Metallosis-Injury-Attorney.jpg

According to the FDA health experts there is no compelling reason to continue using metal-on-metal hip implants. There is overwhelming and mounting evidence that these metal on metal devices can break down early and expose patients to dangerous metallic particles, a condition known as metallosis.

FDA Expert Panel Report

As a Yaz, Yasmin and Ocella pulmonary embolism attorney, I have written extensively about the venous thrombo-embolism (VTE) side effects from Drospirenone containg oral contraceptive pills.

Beyaz is an oral contraceptive approved by the FDA in 2010, that contains folate (0.451 mg of levomefolate calcium). It is a “fourth generation” form of birth control that contains drospirenone, a new type of synthetic progestin. Drospirenone has been linked to potentially deadly side effects, including pulmonary embolism (PE), Deep Vein Thrombosis and Stroke.

Yaz-Beyaz-Pulmonary-Embolism-attorney.JPG

What is Beyaz?

As a DePuy ASR hip implant recall and DePuy Pinnacle attorney, I have written previously about our experience with clients who had metal on metal hip replacement problems, particularly DePuy ASR, DePuy Pinnacle and Biomet Magnum models.

DePuy-ASR-Metallosis-Injury-Attorney.jpg

Metal on metal hip replacements according to experts, have been implanted in at least 500,000 Americans. Now these experts are alarmed and concerned that these metal on metal hips may be failing earlier than expected.

These devices have been the subject to two significant recalls in recent years: the 2008 recall of Zimmer’s Durom Acetabular Component because of inadequate instructions for use, and the 2010 recall of the DePuy ASR Total Hip due to higher-than-expected revision rates.

Beyaz is an oral contraceptive approved by the FDA in 2010, that contains folate (0.451 mg of levomefolate calcium). It is a “fourth generation” form of birth control that contains drospirenone, a new type of synthetic progestin. Drospirenone has been linked to potentially deadly side effects, including pulmonary embolism (PE) and stroke.

Beyaz-Pulmonary-Embolism-Attorney.jpg

What is Beyaz?

Beyaz belongs to the “fourth generation” of birth control pills that contains drospirenone. Other contraceptives in this class include Yaz, Yasmin, Ocella, Gianvi, Loryna, Zarah, Safyral, and Syeda.

According to the latest published medical research, women on combined hormonal birth control drugs, including the NuvaRing vaginal ring, and Yaz, Yasmin and Ocella birth control pills, may face a significantly higher risk of a heart attack or stroke compared to users of other forms of hormonal birth control.

nuvaring-pulmonary-embolism-attorney.jpg

New England Journal of Medicine June 2012 Study

The New England Journal of Medicine published a study on June 14, which suggests that these forms of birth control that contain a combination of estrogen and progestin can double a woman’s risk of having a heart attack or stroke.

Victoza, one of newer diabetes drug has been associated with a number of serious side effects including Thyroid Cancer, Renal (Kidney) Failure and Pancreatitis.

Victoza-Thyroid-Cancer-Attorney.jpg

What is Victoza?

Victoza (liraglutide) is a once-daily, injectable diabetes drug used to help control blood sugar (glucose) in adults with type 2 diabetes.Victoza, made by Novo Nordisk, is an injectable diabetes medication that belongs to a class of drugs that mimic a hormone GLP-1.

Recently plaintiff attorneys have filed a motion to consolidate Pradaxa lawsuits that are currently on file in the U.S. District Courts federal court system.

The motion requests the Judicial Panel on Multidistrict litigation (JPML) to create a MDL (multidistrict litigation), for all Pradaxa product liability lawsuits.

Pradaxa-Wrongful-Death-Attorney.jpg

There are more than 20 lawsuits filed against Pradaxa drug manufacturer, Boehringer Ingelheim. All of the lawsuits allege that the drug maker failed to adequately warn about the side effects of Pradaxa.

According to Johnson & Johnson (JNJ)’s Ethicon unit, the company has announced in a letter this week that it intends to stop selling four vaginal mesh implants. The letter was sent to the court overseeing the Vaginal Mesh lawsuits.

Ethicon_Gynecare_Transvaginal_Mesh_Lawsuits.jpg

Johnson & Johnson said it has requested approval from the Food and Drug Administration to stop “commercializing” the devices

FDA Warnings

Contact Information